Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
Showing 541–600 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
…. Rituximab showed the highest response rate (86%), followed by mycophenolate mofetil (76.9%) and hydroxychloroquine (75%) ( table 1).Abstract PO:10:…
… appropriateness of outcome measures, and lack of control group.BMS-986353 is a CD19-directed CAR T cell therapy, manufactured using the n…
… without requiring chronic immunosuppressive drugs are lacking. Rese-cel is an investigational, fully human, autologous 4-1BB CD19-CAR T…
…o changes in CD25 and CD69 levels were observed.Conclusions The peptides reduced the extent of the immune response, as measured by expre…
…emic Lupus Erythematosus (SLE) is a chronic autoimmune disease. Anifrolumab, a monoclonal antibody targeting the type I interferon receptor…
… trial evaluating the efficacy and safety of different doses of cenerimod (0·5 mg, 1 mg, 2 mg, or 4mg) in subjects with moderate-to-sever…
… (p=0.028), and higher PSD (p<0.001). Higher PhGA was linked to methotrexate (p=0.025), azathioprine (p=0.011), and biologics (p<0.001). Bet…
… phenotypes and to explore potential immunometabolic effects of dapagliflozin in lupus nephritis.Methods Thirty-six female SLE patients were …
…ce: IL-16 and soluble CD163 (sCD163) for histological activity, Tenascin C for renal function loss, and BAFF for B cell activity.Results A…
…pressant, 36 (13.3%) Belimumab, 14 (5.2%) Anifrolumab, 4 (1.5%) Rituximab, and only 46 (17%) glucocorticoids, of whom 80.4% were on doses…
…ale fertility.Conclusions In this landmark long-term follow-up, ICG318 exhibited remarkable safety and efficacy achieving durable sCR …
…ely associated with remission in model 2. Higher daily baseline prednisone dose was negatively associated with sustained remission in mode…